COLT - Cohort in lung transplantation

Head :
Magnan Antoine, L'INSTITUT DU THORAX - INSERM UMR1087 / CNRS UMR 6291

Last update : 07/07/2015 | Version : 2 | ID : 60154

print
Print
xml
XML

Export to XML

Please choose the format :

pdf
PDF
xml
CSV (Excel)

Export to CSV

What sections do you want to export ?

Métadonnées
Identification
General Aspects
Scientific investigator(s) (Contact)
Collaborations
Funding
Governance of the database
Additional contact
Type of database
Database objective
Population type
Dates
Size of the database
Data
Procedures
Promotion
Access
Select all | Invert selection | No selection

Which version do you want to export ?

send
Send
General
Identification
Detailed name Cohort in lung transplantation
Sign or acronym COLT
CNIL registration number, number and date of CPP agreement, AFSSAPS (French Health Products Safety Agency) authorisation CNIL : 911142 ; CPP n°2009-R4 le 24/02/2009 ; Afsapps : B90121-60
General Aspects
Medical area Pneumology
Pathology (details) Lung transplantation
Health determinants Genetic
Keywords Lung Transplantation, Chronique Lung Allograft dy
Scientific investigator(s) (Contact)
Name of the director Magnan
Surname Antoine
Address 44000 NANTES
Phone + 33 (0)2 28 08 01 26
Email antoine.magnan@univ-nantes.fr
Unit L'INSTITUT DU THORAX - INSERM UMR1087 / CNRS UMR 6291
Organization INSERM / CHU DE
Collaborations
Participation in projects, networks and consortia Yes
Details Participation to the SysCLAD European ProjectParticipation to the ENCE network
Funding
Funding status Mixed
Details PHRC NATIONAL 2009 ASSOCIATION VAINCRE LA MUCOVISCIDOSEAGENCE DE BIOMEDECINEINSERM RESEAUX
Governance of the database
Sponsor(s) or organisation(s) responsible CHU DE NANTES
Organisation status Public
Additional contact
Main features
Type of database
Type of database Study databases
Study databases (details) Cohort study
Database recruitment is carried out by an intermediary A selection of health institutions and services
Database recruitment is carried out as part of an interventional study No
Additional information regarding sample selection. Prospective cohort
Database objective
Main objective Highlight preditive factors of the occurrence of chronic lung allograft dysfunction by immunologic, transcriptomics, genomics and proteomics approaches applied to blood and in situ samples performed on
patients.
Inclusion criteria Men and women aged over 18 years who are on the waiting list for lung or cardiopulmonary transplantation or included the day of transplantation, and who give their written inform consent.
Population type
Age Adulthood (19 to 24 years)
Adulthood (25 to 44 years)
Adulthood (45 to 64 years)
Elderly (65 to 79 years)
Population covered Sick population
Gender Male
Woman
Geography area International
Detail of the geography area Multicentric cohort including the 11 French centers for transplantation and the Erasme center in Brussels (Belgium)
Data collection
Dates
Date of first collection (YYYY or MM/YYYY) 09/2009
Date of last collection (YYYY or MM/YYYY) 09/2017
Size of the database
Size of the database (number of individuals) [500-1000[ individuals
Details of the number of individuals 1000 patients included pre-transplantation, from which 750 transplanted patients
Data
Database activity Current data collection
Type of data collected Clinical data
Biological data
Clinical data (detail) Direct physical measures
Medical registration
Details of collected clinical data Clinical examination before trnasplantation and post-transplantaiton every 6 months. Data collected : medical history, concomitant medications, bacterial and viral colonization, episodes of rejection, infections, respiratory function, transplantation complication, immunology, survival
Biological data (detail) A each visit, blood sample for immunological, genomic, and transcriptomic analysis will be collected. According to practices of each centers, induced sputum, Exhaled Air Condensate will also be collected. Broncho Alveolar fuids and transbronchial biopsies will be collected according to the habits of each center.
Presence of a biobank Yes
Contents of biobank Whole blood
Serum
Plasma
Blood cells isolated
Fluids (saliva, urine, amniotic fluid, …)
DNA
DNAc/RNAm
Others
Details of biobank content Biobank: Plasma Bank, Serum Bank, PBMC DNA, RNA, transbronchial biopsy, supernatant of induced sputum, exhaled air condensate, broncho-alveolar liquid
Health parameters studied Health event/morbidity
Health event/mortality
Procedures
Data collection method Manual entry of information collected during medical examination from paper questionnaires, clinical examinations with double input: Direct input Laboratory tests: direct entry
Participant monitoring Yes
Details on monitoring of participants 5 years follow-up
Links to administrative sources Yes
Linked administrative sources (detail) Agence de Biomedecine Database. Exchanges twice a year
Promotion and access
Promotion
Link to the document http://www.ncbi.nlm.nih.gov/pubmed/?term=COLT+AND+Magnan+A[author]
Description List of publications in Pubmed
Access
Terms of data access (charter for data provision, format of data, availability delay) Possible data use by academic teams via approval of the Scientific Council of the cohort. Data can be used by industry via approval of the Director commitee of the cohort.
Access to aggregated data Access on specific project only
Access to individual data Access on specific project only

Partners - FAQ - Contact - Site map - Legal notices - Administration - Updated on December 15 2020 - Version 4.10.05